Acute hepatitis secondary to parenteral amiodarone does not preclude subsequent oral therapy-Reference-Cited by-同舟云学术

Acute hepatitis secondary to parenteral amiodarone does not preclude subsequent oral therapy

Published:2012 Issue:6 Volume:4 Page:196
ISSN:1948-5182
Container-title:World Journal of Hepatology
language:en
Short-container-title:WJH

Author:

Lahbabi Mounia

Publisher

Baishideng Publishing Group Inc.

Subject

Hepatology

Reference12 articles.

1. Amiodarone-induced Hepatitis and Polyneuropathy

2. Hepatic Cirrhosis Caused by Low-Dose Oral Amiodarone Therapy

3. McGovern B, Garan H, Kelly E, Ruskin JN. Adverse reactions during treatment with amiodarone hydrochloride. Br Med J (Clin Res Ed) 1983;287:175-180.

4. James PR, Hardman SM. Acute hepatitis complicating parenteral amiodarone does not preclude subsequent oral therapy. Heart 1997;77:583-584.

5. Paniagua Clusells J, Arcusa Gavalda R, Goma Masip F, Pons Masanes S, Soler Masana JM. [Acute hepatitis caused by intravenous amiodarone]. Rev Esp Cardiol 1996;49:384-385.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute hepatotoxicity of intravenous amiodarone in a Becker muscular dystrophy patient with decompensated heart failing and ABCB4 gene mutation: as assessed for causality using the updated RUCAM;Journal of Cardiothoracic Surgery;2024-07-23

2. A Rare Case of Intravenous Amiodarone Toxicity;Cureus;2022-08-13

3. Low-Dose Intravenous Amiodarone-Induced Acute Hepatic Failure;American Journal of Therapeutics;2022-04-21

4. Immediate oral amiodarone re-challenge following the development of parenteral-induced acute liver toxicity;World Journal of Emergency Medicine;2021

5. Risk factors profile for liver damage in cardiac inpatients;Vojnosanitetski pregled;2020